Quest Diagnostics (DGX) released earnings for third quarter that dropped from the same period last year.
The company's profit came in at $505 million, or $4.02 per share. This compares with $568 million, or $4.14 per share, in last year's third quarter.
Excluding items, Quest Diagnostics reported adjusted earnings of $498 million or $3.96 per share for the period.
Analysts had expected the company to earn $2.87 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 0.7% to $2.77 billion from $2.79 billion last year.
Quest Diagnostics earnings at a glance:
-Earnings (Q3): $498 Mln. vs. $591 Mln. last year.-EPS (Q3): $3.96 vs. $4.31 last year.-Analysts Estimate: $2.87 -Revenue (Q3): $2.77 Bln vs. $2.79 Bln last year.
-Guidance:Full year EPS guidance: $13.50 - $13.90Full year revenue guidance: $10.45 - $10.60 Bln
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.